Treating safety research like other clinical studies slows progress

Progress in patient safety research could slow to a crawl unless regulators work out a host of ethical issues, Johns Hopkins researchers assert in an upcoming opinion piece.

“We can’t apply a clinical paradigm to patient safety research. It just isn’t the right fit,” says Nancy Kass, Sc.D., deputy director for public health at the Johns Hopkins Berman Institute of Bioethics and an author of the article.

The piece, published in the June issue of The Joint Commission Journal on Quality and Patient Safety, was sparked by a 2006 study led by Peter Pronovost, M.D., Ph.D., professor of anesthesiology, critical care medicine, and surgery at the Johns Hopkins University School of Medicine. In the study, Pronovost, an expert on patient safety, implemented a checklist in intensive care units (ICUs) at 67 Michigan hospitals aimed at preventing bloodstream infections whenever doctors insert catheters.

The results were markedly positive: Bloodstream infections from catheters fell by two-thirds, and on average, infection rates in the ICUs went from 4 percent to zero. Over the course of the study, the program saved more than 1,500 lives and nearly $200 million.

Shortly after the study’s results were published, however, an anonymous complaint led to a federal reexamination of the ethical oversight of the study. As in most human research, Pronovost’s study had been reviewed by an institutional review board (IRB)—an internal group required at most research institutions to use federal regulations to make sure research studies protect the welfare of human subjects.

Because Pronovost’s study enforced safety measures already known to be effective, and because no data were ever collected from patients by name, the Johns Hopkins IRB classified Pronovost’s study as “exempt” from further IRB review. This designation meant that informed consent was not necessary from the ICU patients and that IRB review from each of the 67 Michigan hospitals that participated wasn’t required. However, after the anonymous complaint, the federal Office for Human Research Protections, a branch of the U.S. Department of Health and Human Services that oversees IRBs, determined that patient consent and Michigan hospital IRB review should have taken place.

According to Kass, who served for more than 10 years on a Johns Hopkins IRB and is an expert in the ethics of human research, such a decision ignores the differences between patient safety research of this sort and other types of research that include riskier and more burdensome interventions and procedures, such as human trials for new drugs.

While well-informed consent is crucial for all patients participating in new drug research, for example, it may not be necessary for studies like Pronovost’s research, in which the proposed intervention—a checklist to remember to follow steps, all known to make the ICU safer—is virtually risk-free, where data are lumped together so individual patients’ names and information are never collected, and where the consent process may be burdensome to very sick patients. Also, according to Kass, since many small hospitals don’t have IRBs, requiring every hospital to get an IRB review for patient safety evaluations would hinder many hospitals from participating in these studies and contributing their experiences to widespread evaluations.

“All of us want to make sure that patients are protected in any type of research,” said Kass, “but it is also critical to recognize which studies are low risk and should easily move through the system, and which ones are high risk and require considerably more scrutiny.”

Kass adds that working through these issues is crucial to advancing patient safety research, a field that has the potential to greatly advance public health.

“When the public thinks about important medical research, they might think about a cure for a horrible disease. I think the average person has heard very little about the fact that many more people die in the hospital of medical errors than they do from lots of diseases,” she says.

“There is an ethical imperative to do patient safety research,” she adds. “We need to find a review system that works so that important research in this field won’t be compromised.”

Source: Johns Hopkins Medical Institutions

Related stories:

Study tackles labeling errors
With a long-held commitment to continuously improving the quality and safety of patient care, Mayo Clinic researchers are recommending a new technologically-advanced labeling system aimed at reducing specimen labeling errors in a high-volume gastrointestinal endoscopy center. That conclusion is based on the results of a study they are presenting at the 2008 American College of Gastroenterology (ACG) Annual Meeting.
Major study of opiate use in children's hospitals provides simple steps to alleviate harm
Hospitalized kids with painful ailments from broken bones to cancer are often dosed with strong, painkilling drugs known as opiates. The medications block pain, but they can have nasty side effects. Constipation, for instance, is one side effect that can cause discomfort ­ and even extend a child's hospital stay.
Patients will face delays in getting diagnostic scans due to severe shortage of imaging agents
A global shortage of medical isotopes* used in over 80% of routine diagnostic nuclear imaging procedures such as heart imaging, bone scans and some cancer detection procedures, will cause delays and cancellations to diagnostic examinations across the UK and Europe in the next few weeks, predict experts on bmj.com today.
Bisphenol A linked to metabolic syndrome in human tissue
New research from the University of Cincinnati (UC) implicates the primary chemical used to produce hard plastics—bisphenol A (BPA)—as a risk factor for metabolic syndrome and its consequences.
Researchers use virtual reality to study complexities of dizziness
Think back to when you slipped on the ice or in the shower: the ground rushing up, your feet shooting out, terror building even as your mind is working a mile a second to plot a soft landing.
All types of antipsychotic drugs increase the risk of stroke
All drugs used to treat psychosis are linked to an increased risk of stroke, and dementia sufferers are at double the risk, according to a study published on bmj.com today.
Study finds a wide variety of errors in testing process at family medicine clinics
The largest study to date of testing errors reported by family physician offices in the United States found that problems occur throughout the testing process and disproportionately affect minority patients.
Researchers examine safety of Internet prescriber service providing erectile dysfunction medications
Online Internet shopping today offers many benefits. You can research a product in the privacy of your own home and purchase most anything by clicking a mouse. But should we be allowed to buy prescription drugs via the Internet, bypassing a traditional office visit or conversation with a physician?

News discussion:

Medicine & Health news